Emcure Pharmaceuticals Limited — Others, 25-03-2025: Trading Window

Emcure Pharmaceuticals Limited has announced the closure of the trading window for its securities, effective April 01, 2025, until 48 hours post the disclosure of the financial results for the quarter and half-year ending March 31, 2025. This move aligns with internal compliance measures to regulate insider trading. The date for the board meeting to approve the financial results will be communicated in due course. Investors should note this as it may reflect on trading activity, with potential implications for share availability as key results are awaited, likely impacting sentiment in the near term.